2024-11-17 11:33:08
CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition
Health/ 2023-07-22
CRT 2023 selects Syntach Cardiac Support...

LUND,Sweden,Feb. 22,2023-- Syntach AB ("Syntach") is pleased to announce that the Company\'s Syntach Cardiac Support system (Synta...

Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multip
Health/ 2023-07-22
Karyopharm and Menarini Group Receive Fu...

– Based on Results from Phase 3 BOSTON Study,Marketing Authorization Expands Multiple Myeloma Indication –

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release